Given that TMPRSS2-ERG increases both the migration in vitro and the subcutaneous tumor development, we then tested whether TMPRSS2-ERG could be taking part in the bone metastasis formation of prostate cancer cells in vivo. The gene discussed is TMPRSS2; the disease is prostate cancer.